Cannabinol is the nonenzymatic oxidation byproduct of THC and is most commonly an artifact found after prolonged storage, especially at higher temperatures. CBN was the first cannabinoid to be identified and isolated from cannabis.
Unlike many other cannabinoids, cannabinol (CBN) does not stem from cannabigerol (CBG). Instead, CBN is a tetrahydrocannabinol (THC) metabolite formed as cannabis ages. THC degrades into CBN over time and exposure to ultraviolet (UV) light.
CBN retains some THC’s psychoactivity but is significantly less psychoactive than THC. THCA converts into cannabinolic acid (CBNA), converted into CBN when decarboxylated or heated.
It’s no secret that CBN is the “sleepy cannabinoid.” Still, beyond insomnia, CBN can also be used to treat multiple sclerosis (MS), Crohn’s Disease, chronic pain, and many other challenging conditions.
However, there is much debate surrounding CBN’s effects. Some claim it has a slight psychoactive effect, while others suggest barely any effect.
CBN could be useful as a supplemental treatment for the following issues:
Pain. CBN is a mild painkiller and anti-inflammatory.
Seizures. CBN is shown to be an anti-epileptic that provides a sedative effect and could help treat seizures and convulsions.
Loss of Appetite.Appetite stimulants may be beneficial for people experiencing chemotherapy-induced nausea and appetite reduction.
Viruses and Illnesses. Antibacterial – CBN could slow bacterial growth, making it worthwhile to treat superbugs like MRSA.
Insomnia.CBN has sedative effects, which have been reported in some instances to be stronger than those of Valium, making it a cannabinoid of interest when it comes to replacing prescription sedatives.
In addition, CBN shows even greater promise than THC and CBD as a neuroprotectant and treatment for glaucoma. A CBN-rich formula developed by InMed Pharmaceuticals shows that CBN can lower intraocular (inner eye) pressure. CBN’s therapeutic effects for diabetes and hypertension mean it acts as a possible treatment for glaucoma.